Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 433-440

  Padovani, Laetitia ^a   Sunyach, Marie Pierre ^b   Perol, David ^b   Mercier, Cedric ^a   Alapetite, Claire ^c   Haie Meder, Christine ^d   Hoffstetter, Sylvette ^e   Muracciole, Xavier ^a   Kerr, Christine ^f   Wagner, Jean Philippe ^g   Lagrange, Jean Léon ^h   Maire, Jean Philippe ⁱ   Cowen, Didier ^a   Frappaz, Didier ^b   Carrie, Christian ^b  

^a TIMONE HOSPITAL   (France)

^b CENTRE LÉON BÉRARD   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE ALEXIS VAUTRIN   (France)

^f CENTRE VAL D AURELLE   (France)

^g Clinique de l'Orangerie Strasbourg   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Adults; Medulloblastoma; Radiotherapy

Indexed keywords

BRAIN; CHEMOTHERAPY; DISEASES; LIVING SYSTEMS STUDIES; PATIENT TREATMENT; RADIOLOGY;

ADULTS; MEDULLOBLASTOMA; PROGNOSTIC FACTORS; UNIVARIATE ANALYSIS;

ONCOLOGY;

ADULT; ARTICLE; BRAIN STEM; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PERFORMANCE; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOLOGIST; RELAPSE; RETROSPECTIVE STUDY; SURGEON; SURVIVAL; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CEREBELLAR NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDULLOBLASTOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34247849227     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.030     Document Type: Article

References (38)

1. Packer R.J., Cogen P., Vezina G., et al. Medulloblastoma: Clinical and biologic aspects. Neurooncology 1 (1999) 232-250
2. Spreafico F., Massimino M., Gandola L., et al. Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 41 (2005) 1304-1310
3. Carrie C., Lasset C., Alapetite C., et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer 74 (1994) 2352-2360
4. Frost P.J., Laperriere N.J., Wong C.S., et al. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32 (1995) 951-957
5. Hartsell W.F., Montag A.G., Lydon J., et al. Treatment of medulloblastoma in adults. Am J Clin Oncol 15 (1992) 207-211
6. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
7. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
8. Cox D.R. Regression models and life tables. J R Stat Soc Ser B 34 (1972) 187-202
9. Chastagner P., Olive D., Philip T., et al. Efficacy of the "8 drugs in a day" protocol in brain tumors in children. [French]. Arch Fr Pediatr 45 (1988) 249-254
10. Gentet J.C., Doz F., Bouffet E., et al. Carboplatin and VP 16 in medulloblastoma: A phase II study of the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 23 (1994) 422-427
11. Pendergrass T.W., Milstein J.M., Geyer J.R., et al. Eight drugs one day chemotherapy for brain tumors: Experience in 107 children and rational for preradiation chemotherapy. J Clin Oncol 5 (1987) 1221-1231
12. Chan A.W., Tarbell N.J., Black P.M., et al. Adult medulloblastoma: Prognostic factors and patterns of relapse. Neurosurgery 47 (2000) 623-631
13. Taylor R.E., Bailey C.C., Robinson K.J., et al. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 58 (2004) 1184-1193
14. Danjoux C.E., Jenkin R.D., McLaughlin J., et al. Childhood medulloblastoma in Ontario, 1977-1987: Population-based results. Med Pediatr Oncol 26 (1996) 1-9
15. Packer R.J., Sutton L.N., Goldwein J.W., et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74 (1991) 433-440
16. Park T.S., Hoffman H.J., Hendrick E.B., et al. Medulloblastoma: Clinical presentation and management. Experience at the Hospital for Sick Children, Toronto, 1950-1980. J Neurosurg 58 (1983) 543-552
17. Kopelson G., Linggood R.M., and Kleinman G.M. Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer 51 (1983) 312-319
18. Sharma B.S., Kak V.K., Mittal R.S., et al. Medulloblastoma in adults-Clinical observations and results of treatment. Indian J Cancer 26 (1989) 156-163
19. Bloom H.J., and Bessell E.M. Medulloblastoma in adults: A review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 18 (1990) 763-772
20. Giordana M.T., Duo D., Gasverde S., et al. MDM2 overexpression is associated with short survival in adults with medulloblastoma. Neurooncology 4 (2002) 115-122
21. Zeltzer P.M., Boyett J.M., Finlay J.L., et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17 (1999) 832-845
22. Choux M., Lena G., and Hassoun J. Prognosis and long-term follow-up in patients with medulloblastoma. Clin Neurosurg 30 (1983) 246-277
23. Kortmann R.D., Kuhl J., Timmermann B., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46 (2000) 269-279
24. Carrie C., Muracciole X., Gomez F., et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 1 (2005) 711-716
25. Thomas P.R., Deutsch M., Kepner J.L., et al. Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18 (2000) 3004-3011
26. Carrie C., Lasset C., Blay J.Y., et al. Medulloblastoma in adults: Survival and prognostic factors. Radiother Oncol 29 (1993) 301-307
27. Hughes E.N., Shillito J., Sallan S.E., et al. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer 61 (1988) 1992-1998
28. Kopelson G., Linggood R.M., and Kleinman G.M. Medulloblastoma in adults: Improved survival with supervoltage radiation therapy. Cancer 49 (1982) 1334-1337
29. Chin H.W., and Maruyama Y. Prognostic factors in medulloblastoma. Am J Clin Oncol 5 (1982) 359-369
30. Silverman C.L., and Simpson J.R. Cerebellar medulloblastoma: The importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8 (1982) 1869-1876
31. Brandes A.A., Ermani M., Amista P., et al. The treatment of adults with medulloblastoma: A prospective study. Int J Radiat Oncol Biol Phys 57 (2003) 755-761
32. Oyharcabal-Bourden V., Kalifa C., Gentet J.C., et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 23 (2005) 4726-4734
33. Grill J., Renaux V.K., Bulteau C., et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45 (1999) 137-145
34. Mulhern R.K., Kepner J.L., Thomas P.R., et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol 16 (1998) 1723-1728
35. Mulhern R.K., Reddick W.E., Palmer S.L., et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 46 (1999) 834-841
36. Fouladi M., Chintagumpala M., Laningham F.H., et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 22 (2004) 4551-4560
37. Carrie C., Alapetite C., Mere P., et al., The French Medulloblastoma Group. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to tumour relapse. Radiother Oncol 24 (1992) 77-81
38. Carrie C., Hoffstetter S., Gomez F., et al. Impact of targeting deviations on outcome in medulloblastoma: Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 45 (1999) 435-439